Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Neoplasm Metastasis 5Ovarian Neoplasms 4Neoplasms 3Multiple Myeloma 3Metastatic Castration-resistant Prostate Cancer 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lymphoma, B-Cell 2Endometrial Neoplasms 2Breast Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomatitis 1Stomach Neoplasms 1Recurrence 1Prostate Cancer Metastatic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oral Ulcer 1Myasthenia Gravis 1Metastatic Castration-Resistant Prostate Cancer Patients 1Metastatic Castration-Resistant Prostate Cancer 1Hodgkin Disease 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

enzalutamide 5Prednisone 5cabazitaxel 4Docetaxel 3Abiraterone Acetate 3fludrocortisone acetate 1Zuclomiphene 1XRP6258 1Standard of Care 1Prednisolone 1Midazolam 1LY3023414 1Injections 1Hydrocortisone 1Dexamethasone 1Abituzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Prostate Cancer Metastatic × Prednisolone × Clear all
NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Sanofi

Phase 4 Completed
10 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡